Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Daily News

Mobile Stroke Units Hasten Triage Even in Dense Cities

Caitlin E. Cox

December 04, 2019

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

L.A. McKeown

November 26, 2019

News Conference News VIVA 2019

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

L.A. McKeown

November 08, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Opinion Off Script TCT 2019

Off Script: The New Gatekeepers of Procedural Education

Kwan S. Lee

September 28, 2019

News Opinion Off Script

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Mamas Mamas, BMBCh

August 23, 2019

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Industry News

Thrombolex, Inc. Announces 510(K) Premarket Notification Clearance Of The Bashir™ Endovascular Catheter And The Bashir N-X™ Endovascular Catheter For The Treatment Of Acute Venous And Arterial Thromboembolic Disorders

May 13, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Conference News ISC 2019

Mechanical Thrombectomy Outcomes May Be Worse at Low-Volume Stroke Centers

Todd Neale

February 07, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Shelley Wood

January 21, 2019

News Daily News

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Michael O'Riordan

January 17, 2019

Advertisement

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Mobile Stroke Units Hasten Triage Even in Dense Cities

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

Off Script: The New Gatekeepers of Procedural Education

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

Thrombolex, Inc. Announces 510(K) Premarket Notification Clearance Of The Bashir™ Endovascular Catheter And The Bashir N-X™ Endovascular Catheter For The Treatment Of Acute Venous And Arterial Thromboembolic Disorders

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

Mechanical Thrombectomy Outcomes May Be Worse at Low-Volume Stroke Centers

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content